Venugopal, V. et al. 2026. Rosuvastatin Monotherapy Versus Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity, Vascular Inflammation, and Lipid Profile In Patients With Type 2 Diabetes Mellitus: A Randomised Controlled Trial. Adolescência e Saúde. (Sep. 2026), 636–648.